pilocarpine has been researched along with 4-(alpha-(4-allyl-2,5-dimethyl-1-piperazinyl)-3-methoxybenzyl)-n,n-diethylbenzamide in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bausch, SB; Garland, JP; Yamada, J | 1 |
1 other study(ies) available for pilocarpine and 4-(alpha-(4-allyl-2,5-dimethyl-1-piperazinyl)-3-methoxybenzyl)-n,n-diethylbenzamide
Article | Year |
---|---|
The delta opioid receptor agonist, SNC80, has complex, dose-dependent effects on pilocarpine-induced seizures in Sprague-Dawley rats.
Topics: Animals; Anticonvulsants; Benzamides; Convulsants; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Interactions; Epilepsy, Temporal Lobe; Hippocampus; Male; Mossy Fibers, Hippocampal; Muscarinic Agonists; Narcotics; Pilocarpine; Piperazines; Rats; Rats, Sprague-Dawley; Reaction Time; Receptors, Opioid, delta; Seizures | 2005 |